• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      Pharma cos to give drugs at cost price to the poor

      Posted AtEconomic Times

      NEW DELHI: Leading domestic drug makers, including Wockhardt, Ranbaxy, Dr Reddy's, Lupin and Sun Pharma, have agreed to provide medicines at cost price to the poor in return for a no-price control regime. The companies, represented by the Indian Pharmaceutical Alliance (IPA) that enjoys the largest share of the local pharma market, told a task force appointed by the PM that the new drug policy should provide for affordable medicines to the people below poverty line, while ensuring a price control-free regime to the industry, which needs research investments to sustain the ri- gours of a product patent era.

      July 17, 2005


      Share this Article!

    Back to top^